热门资讯> 正文
Tempus AI在BTIG收购
2025-04-22 01:50
- Tempus AI (NASDAQ:TEM) has been initiated with a Buy rating at BTIG, banking on the company's growing precision medicine platform technology through AI-driven diagnostics.
- "We believe the company's AI applications (algos) and data business represent a significant free call option for investors," analysts at BTIG said.
- BTIG has initiated the company at a PT of $60, adding that the company has done a good job in its early days to monetize its genomics and data business to medical oncologists and with pharma companies.
- The stock of the company has risen 16% YTD.
More on Tempus AI
- Tempus: The AI Engine Powering Healthcare
- Tempus AI's Valuation Bakes In Strong Growth - A Hold For Now
- Tempus AI: The Investment Opportunity Of A Decade, Strong Buy
- Cathie Wood bought the dip on Tempus AI, grabbing over 400K shares after a 15% drop
- Tempus AI stock tumbles 19% in wake of Q4 earnings report
推荐文章
美股机会日报 | 今夜凌晨2点！会议纪要将揭露美联储内部分歧；塔吉特、雅诗兰黛绩后重挫
意外吗？英伟达是“最被低配”的大盘科技美股
港股异动 | 两大新消费“龙头”业绩喜人带动板块大涨！泡泡玛特绩后飙涨13%
新股申购 | 佳鑫国际一手入场费4412.06港元！IPO前江西铜业持股超41%
华盛早报丨涨近24%→跌超20%！东方甄选俞敏洪紧急回应；光伏再开反内卷会议
8月20日外盘头条：美国扩大钢铁和铝关税范围 白宫考虑在布达佩斯举行俄乌会谈 标普维持美国信用评级
一图看懂 | 亏损大幅收窄！小鹏Q2净亏损4.8亿元，去年同期12.8亿元；汽车交付量创历史新高
家得宝将公布第二季度财报，华尔街关注其美国销售额能否实现连续三季度增长
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
